Smith & Nephew (LON:SN) Stock Price Crosses Above 200 Day Moving Average - Here's Why

Shares of Smith & Nephew plc (LON:SN - Get Free Report) passed above its two hundred day moving average during trading on Tuesday . The stock has a two hundred day moving average of GBX 1,121.01 ($15.14) and traded as high as GBX 1,391.21 ($18.79). Smith & Nephew shares last traded at GBX 1,387 ($18.73), with a volume of 1,199,494 shares trading hands.

Analyst Upgrades and Downgrades

A number of equities research analysts have recently issued reports on SN shares. Deutsche Bank Aktiengesellschaft increased their target price on Smith & Nephew from GBX 1,300 to GBX 1,400 and gave the company a "hold" rating in a research note on Wednesday, August 6th. Berenberg Bank increased their target price on Smith & Nephew from GBX 1,100 to GBX 1,300 and gave the company a "hold" rating in a research note on Thursday, August 7th. Finally, JPMorgan Chase & Co. increased their target price on Smith & Nephew from GBX 1,357 to GBX 1,438 and gave the company an "overweight" rating in a research note on Wednesday, August 6th. One analyst has rated the stock with a Buy rating and two have issued a Hold rating to the company. Based on data from MarketBeat.com, Smith & Nephew currently has an average rating of "Hold" and a consensus price target of GBX 1,379.33.

Smith & Nephew Trading Up 0.4%

The company has a debt-to-equity ratio of 70.22, a quick ratio of 0.84 and a current ratio of 2.51. The business has a fifty day simple moving average of GBX 1,240.27 and a 200 day simple moving average of GBX 1,127.89. The company has a market cap of £15.52 billion, a P/E ratio of 50.98, a P/E/G ratio of 0.46 and a beta of 0.62.

Insider Activity at Smith & Nephew

In other news, insider Katarzyna Mazur Hofsaess bought 541 shares of Smith & Nephew stock in a transaction on Friday, August 22nd. The shares were bought at an average price of GBX 1,385 per share, with a total value of £7,492.85. Also, insider David King acquired 2,800 shares of the stock in a transaction that occurred on Monday, August 18th. The shares were acquired at an average cost of GBX 3,631 per share, with a total value of £101,668. Insiders have purchased a total of 4,811 shares of company stock worth $12,947,701 over the last quarter. 0.19% of the stock is owned by corporate insiders.

Smith & Nephew Company Profile

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom and internationally. It operates through three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products.